drugset / Trial / NCT05302596
Semaglutide Use in Elderly Obese Patients
Phase 2
Completed
16 enrolled
State University of New York at Buffalo
National Center for Advancing Translational Sciences (NCATS) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a single-center, prospective, controlled, randomized and open label study to investigate the effect of the semaglutide addition to standard of care weight loss intervention (personalized lifestyle and exercise) in elderly obese subjects on body weight and body composition as assessed by DEXA.
Timeline
- Start
- 2022-09-01
- Primary completion
- 2023-10-23
- Completion
- 2024-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 1 mg | Other |